Inhibrx Biosciences (INBX) Tax Provisions (2023 - 2025)
Inhibrx Biosciences (INBX) reported Tax Provisions of $2000.0 for Q2 2025, little changed year-over-year from $2000.0 in Q2 2024, and little changed quarter-over-quarter from $2000.0 in Q2 2024.
Inhibrx Biosciences (INBX) Tax Provisions (2023 - 2025) Analysis & Trends
Inhibrx Biosciences (INBX) has 3 years of Tax Provisions data on file, last reported at $2000.0 in Q2 2025.
- Tax Provisions for Q2 2025 came in at $2000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $2000.0 (changed 0.0% YoY), and the FY2025 annual result was $2000.0, changed 0.0% from the prior year.
- Tax Provisions was little changed at $2000.0 in Q2 2025 per INBX's latest filing, from $2000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $5000.0 in Q2 2023 and troughed at -$4000.0 in Q4 2023.
- A 3-year average of $1400.0 and a median of $2000.0 in 2023 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2024 and 2025: Tax Provisions plunged 60.0% in 2024, then changed 0.0% in 2025.
- A 3-year view of Tax Provisions shows it stood at -$4000.0 in 2023, then surged by 150.0% to $2000.0 in 2024, then changed by 0.0% to $2000.0 in 2025.
- Business Quant data shows INBX's Tax Provisions at $2000.0 in Q2 2025, $2000.0 in Q2 2024, and -$4000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Inhibrx Biosciences | 186.16 Mn | 186.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Dec 31, 2023 | -4,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 5,000.00 |